CO2019008755A2 - Vacuna recombinante contra helmintos en pichia pastoris y procesos de purificación y producción de proteínas como vacuna contra helmintos - Google Patents

Vacuna recombinante contra helmintos en pichia pastoris y procesos de purificación y producción de proteínas como vacuna contra helmintos

Info

Publication number
CO2019008755A2
CO2019008755A2 CONC2019/0008755A CO2019008755A CO2019008755A2 CO 2019008755 A2 CO2019008755 A2 CO 2019008755A2 CO 2019008755 A CO2019008755 A CO 2019008755A CO 2019008755 A2 CO2019008755 A2 CO 2019008755A2
Authority
CO
Colombia
Prior art keywords
pichia pastoris
vaccine against
production
against helminths
protein
Prior art date
Application number
CONC2019/0008755A
Other languages
English (en)
Inventor
Andrew J G Simpson
Celso Raul Romero Ramos
Miriam Tendler
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Publication of CO2019008755A2 publication Critical patent/CO2019008755A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

RESUMEN La presente invención se refiere a la producción recombinante de proteínas al utilizar un gen sintético para alta expresión de proteína en Pichia pastoris; más específicamente, la invención describe la producción de proteína recombinante Sm14 Schistosoma mansoni, en donde un gen sintético se creó para promover alta expresión de dicha proteína, un gen que se clonó bajo el control de dos tipos de promotores de Pichia pastoris: promotor inducible por metanol (AOXI) y promotor constituyente (GAP); con estas construcciones, las cepas de Pichia pastoris se manipularon genéticamente para producir de manera eficiente el antígeno de vacuna Sm14; los procesos para producir y purificar esta proteína de las células de P. pastoris, que se pueden escalar para su Producción industrial, también se mejoraron.
CONC2019/0008755A 2017-01-23 2019-08-12 Vacuna recombinante contra helmintos en pichia pastoris y procesos de purificación y producción de proteínas como vacuna contra helmintos CO2019008755A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102017001309-0A BR102017001309A2 (pt) 2017-01-23 2017-01-23 vacina recombinante para helmintos em pichia pastoris, e, processos de produção e purificação de proteína como vacina para helmintos
PCT/BR2018/000001 WO2018132882A1 (pt) 2017-01-23 2018-01-22 Vacina recombinante para helmintos em pichia pastoris, e, processos de produção e purificação de proteína como vacina para helmintos

Publications (1)

Publication Number Publication Date
CO2019008755A2 true CO2019008755A2 (es) 2020-01-17

Family

ID=62907480

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2019/0008755A CO2019008755A2 (es) 2017-01-23 2019-08-12 Vacuna recombinante contra helmintos en pichia pastoris y procesos de purificación y producción de proteínas como vacuna contra helmintos

Country Status (9)

Country Link
US (1) US20200010515A1 (es)
EP (1) EP3572514A4 (es)
AR (1) AR111507A1 (es)
AU (1) AU2018210684A1 (es)
BR (1) BR102017001309A2 (es)
CA (1) CA3050981A1 (es)
CO (1) CO2019008755A2 (es)
MX (1) MX2019008681A (es)
WO (1) WO2018132882A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102021012953A2 (pt) 2021-06-29 2023-01-10 Fabp Biotech Desenvolvimento Em Biotecnologia Ltda. Composição de vacina veterinária contra helmintos, método para tratamento e prevenção de infecção causada por helmintos e uso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0303266B8 (pt) * 2003-01-31 2021-05-25 Fundacao Oswaldo Cruz proteína recombinante sm14, composição imunogênica, e,kit de diagnóstico.
BRPI1005855B1 (pt) 2010-09-17 2020-04-22 Fundação Oswaldo Cruz processos de produção e purificação de proteina sml 4 recombinante em pichia pastoris

Also Published As

Publication number Publication date
EP3572514A4 (en) 2020-12-02
WO2018132882A1 (pt) 2018-07-26
AU2018210684A1 (en) 2019-09-12
US20200010515A1 (en) 2020-01-09
MX2019008681A (es) 2019-12-09
CA3050981A1 (en) 2018-07-26
AR111507A1 (es) 2019-07-24
BR102017001309A2 (pt) 2018-08-14
EP3572514A1 (en) 2019-11-27

Similar Documents

Publication Publication Date Title
AR124871A2 (es) Métodos de fabricación para el control del contenido de lisina c-terminal, galactosa y ácido siálico en proteínas recombinantes
NZ737094A (en) Expression constructs and methods of genetically engineering methylotrophic yeast
BR112015011534A2 (pt) polipeptídeo recombinante de myceliophthera thermophilus, ácido nucleico isolado, vetor recombinante, célula hospedeira recombinante, métodos para produzir um polipeptídeo, para degradar uma biomassa celulósica, para aumentar a produção de proteínas ativas a partir de uma célula hospedeira, e, composição
ECSP12011577A (es) Produccion recombinante de péptidos
BR112015021785A2 (pt) Promotores de levedura para expressão de proteína
AR088252A1 (es) Produccion de una proteina de interes mediante un promotor regulable de pichia pastoris
MX2013013131A (es) Proceso para hacer reaccionar un ester de acido carboxilico.
PE20181334A1 (es) Composiciones relacionadas con una toxina de clostridium difficile mutante y sus metodos
BR112015029985A2 (pt) método para produção de l-leucina, l-valina, l-isoleucina, alfa-cetoisovalerato, alfa-ceto-beta-metilvalerato, ou alfa-cetoisocaproato usando corynebactéria recombinante que contém ilvbn operon, o qual pode ser induzido por propionato
AR086214A1 (es) Composiciones detergentes que contienen mananasa de bacillus agaradhaerens y sus metodos de uso
CL2018000164A1 (es) Vector recombinante del virus orf.
AR102445A1 (es) COMPOSICIONES Y MÉTODOS RELACIONADOS CON b-GLUCOSIDASA
EA201290565A1 (ru) Получение белка гемагглютинин-нейраминидазы в микроводорослях
AR097977A1 (es) Método de producción de l-aminoácidos
BR112016012229A2 (pt) métodos de produção de polipeptídeos
EA201492177A1 (ru) Очистка идуронат-2-сульфатазы
EA201691754A1 (ru) Рекомбинантный микроорганизм, экспрессирующий аналог авермектина, и его применение
MX2019003360A (es) Vectores de expresion para una secrecion de proteina mejorada.
MY169049A (en) Microorganisms for producing putrescine and process for producing putrescine using them
BR112014031526A2 (pt) promotores para expressar um gene em uma célula
CO2017011431A2 (es) Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina
CO2019008755A2 (es) Vacuna recombinante contra helmintos en pichia pastoris y procesos de purificación y producción de proteínas como vacuna contra helmintos
PE20211303A1 (es) Polipeptidos del factor vii de accion corta
CO6450652A2 (es) Alteracion del equilibrio de enzimas mediante condiciones de fermentación
BR112018005464A2 (pt) expressão de proteínas contendo fc